Literature DB >> 7371772

Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.

A Bertolini, M Castelli, S Genedani, M Garuti.   

Abstract

Trimethoprim enhances the in vitro activity of nalidixic and oxolinic acids against some representative pathogenic microorganisms, including those which are most frequently responsible for urinary tract infections, and delays the emergence of resistance in many of them.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7371772     DOI: 10.1007/bf01953757

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  18 in total

1.  Selective inhibition of semiconservative DNA synthesis by nalidixic acid in permeabilized bacteria.

Authors:  T J Simon; W E Masker; P C Hanawalt
Journal:  Biochim Biophys Acta       Date:  1974-05-17

2.  Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.

Authors:  E Atlas; H Clark; F Silverblatt; M Turck
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

3.  [Inhibitory action of nitrofurantoin on the bacteriostatic power in vitro of nalidixic acid].

Authors:  J D Piguet
Journal:  Ann Inst Pasteur (Paris)       Date:  1969-01

4.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

5.  [Antibacterial activity in vitro of nalidixic acid-neomycin].

Authors:  R Auriti; L Ravagnan
Journal:  Antibiotica       Date:  1968-06

6.  Nalidixic acid: clinical and laboratory studies.

Authors:  S M Finegold; L G Miller; D Posnick; D K Patterson; A Davis
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

7.  Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species.

Authors:  K Berneis; W Boguth
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

8.  Inhibition of deoxyribonucleic acid synthesis and bud formation by nalidixic acid in Hyphomicrobium neptunium.

Authors:  R M Weiner; M A Blackman
Journal:  J Bacteriol       Date:  1973-12       Impact factor: 3.490

9.  MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.II. INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS.

Authors:  W A GOSS; W H DEITZ; T M COOK
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

10.  MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.

Authors:  W A GOSS; W H DEITZ; T M COOK
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

View more
  2 in total

1.  Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates.

Authors:  P Huovinen; J S Wolfson; D C Hooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

Review 2.  Antibiotic resistome of Salmonella typhi: molecular determinants for the emergence of drug resistance.

Authors:  Awanish Kumar; Anil Kumar
Journal:  Front Med       Date:  2021-06-04       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.